Income Statement Ovation Science Inc. OTC Markets

Stocks

OVATF

CA69016D1087

Personal Products

Market Closed - OTC Markets Other stock markets 11:23:17 21/04/2026 pm IST			5-day change	1st Jan Change
0.0350 ^USD	-53.95%		-.--%	+18.64%

26/05	Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
01/05	Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

5c.IZbzDO8TJFhzgThwTV2fhne2zUNBR6WD3LzQgbR1_Jg.eMOLeIlWaA4huEBFKjLltTv5mgQQBs_Zmcy5scBBsNZR56drgHlGaDrTeQ

Published financial data: OVATION SCIENCE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2L	1L	61.93T	1L	67.89T
Total Revenues	2L	1L	61.93T	1L	67.89T
Cost of Goods Sold, Total	9L	4.05T	18.67T	27.5T	28.09T
Gross Profit	-7L	1L	43.26T	85.72T	39.8T
Selling General & Admin Expenses, Total	8L	8L	7L	6L	6L
Provision for Bad Debts	-	52	61.29T	-	-
Stock-Based Compensation (IS)	-	-	37.7T	-	68.46T
R&D Expenses	83.07T	65.27T	8.79T	12.53T	-
Depreciation & Amortization - (IS)	8.02T	6.73T	3.24T	2.12T	-
Other Operating Expenses, Total	9L	9L	8L	6L	6L
Operating Income	-15.25L	-7L	-8L	-5L	-6L
Interest Expense, Total	-	-588	-31.08T	-49.93T	-50.36T
Interest And Investment Income	4.72T	3	-	-	-
Net Interest Expenses	4.72T	-585	-31.08T	-49.93T	-50.36T
Currency Exchange Gains (Loss)	-1.93T	-4.17T	343	-266	-
Other Non Operating Income (Expenses)	-1L	-43.88T	-30.76T	73.04T	17.28T
EBT, Excl. Unusual Items	-16.52L	-8L	-8L	-5L	-6L
Asset Writedown	-7L	-	-	-	-
Other Unusual Items	-	-	15.6T	-	-
EBT, Incl. Unusual Items	-23.94L	-8L	-8L	-5L	-6L
Earnings From Continuing Operations	-23.94L	-8L	-8L	-5L	-6L
Net Income to Company	-23.94L	-8L	-8L	-5L	-6L
Net Income - (IS)	-23.94L	-8L	-8L	-5L	-6L
Net Income to Common Incl Extra Items	-23.94L	-8L	-8L	-5L	-6L
Net Income to Common Excl. Extra Items	-23.94L	-8L	-8L	-5L	-6L
Per Share Items
Net EPS - Basic	-0.08	-0.03	-0.03	-0.01	-0.02
Basic EPS - Continuing Operations	-0.08	-0.03	-0.03	-0.01	-0.02
Basic Weighted Average Shares Outstanding	2.94Cr	2.94Cr	3.03Cr	3.5Cr	3.56Cr
Net EPS - Diluted	-0.08	-0.03	-0.03	-0.01	-0.02
Diluted EPS - Continuing Operations	-0.08	-0.03	-0.03	-0.01	-0.02
Diluted Weighted Average Shares Outstanding	2.94Cr	2.94Cr	3.03Cr	3.5Cr	3.56Cr
Normalized Basic EPS	-0.04	-0.02	-0.02	-0.01	-0.01
Normalized Diluted EPS	-0.04	-0.02	-0.02	-0.01	-0.01
Supplemental Items
EBITDA	-15.16L	-7L	-8L	-5L	-6L
EBITA	-15.25L	-7L	-8L	-5L	-6L
EBIT	-15.25L	-7L	-8L	-5L	-6L
EBITDAR	-14.92L	-7L	-6L	-4L	-
Total Revenues (As Reported)	2L	1L	61.93T	1L	67.89T
Normalized Net Income	-10.32L	-5L	-5L	-3L	-4L
Interest on Long-Term Debt	-	165	13.71T	24.3T	19.81T
Supplemental Operating Expense Items
Advertising Expense	33.72T	19.93T	14.13T	3.86T	1.76T
Selling and Marketing Expenses	33.72T	19.93T	14.13T	3.86T	1.76T
General and Administrative Expenses	7L	8L	7L	5L	6L
Research And Development Expense From Footnotes	83.07T	65.27T	8.79T	12.53T	-
Net Rental Expense, Total	24T	44.13T	1L	97.22T	-
Imputed Operating Lease Interest Expense	-	-	3L	2L	-
Imputed Operating Lease Depreciation	-	-	-2L	-71.23T	-
Stock-Based Comp., Other (Total)	-	-	37.7T	-	68.46T
Total Stock-Based Compensation	-	-	37.7T	-	68.46T

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6L	28.9T	48.85T	3.31T	72.29T
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	6L	28.9T	48.85T	3.31T	72.29T
Accounts Receivable, Total	78.78T	53.24T	3.02T	25.01T	4.55T
Other Receivables	15.16T	7.15T	2.05T	6.74T	5.97T
Total Receivables	93.95T	60.39T	5.08T	31.75T	10.53T
Inventory	4T	2.32T	17.24T	28.84T	-
Prepaid Expenses	12.68T	7.78T	3.52T	-	-
Total Current Assets	8L	99.38T	74.69T	63.9T	82.82T
Gross Property Plant And Equipment	30.43T	32.51T	-	-	-
Accumulated Depreciation	-18.72T	-27T	-	-	-
Net Property Plant And Equipment	11.71T	5.5T	2.2T	-	-
Other Intangibles, Total	-	-	-	-	-
Total Assets	8L	1L	76.89T	63.9T	82.82T
Liabilities
Accounts Payable, Total	23.56T	23.82T	56.34T	1L	1L
Accrued Expenses, Total	40.18T	1L	4L	7L	11.16L
Short-term Borrowings	-	23.07T	22.54T	20.68T	23.16T
Current Portion of Long-Term Debt	-	-	2L	2L	3L
Other Current Liabilities	-	-	62.52T	17.79T	-
Total Current Liabilities	63.74T	2L	7L	11.54L	15.42L
Long-Term Debt	-	18.06T	18.27T	-	-
Total Liabilities	63.74T	2L	7L	11.54L	15.42L
Common Stock, Total	42.8L	42.8L	44.55L	45.23L	45.86L
Retained Earnings	-49.85L	-57.79L	-65.92L	-70.48L	-76.79L
Comprehensive Income and Other	14.1L	14.15L	14.84L	14.35L	16.34L
Total Common Equity	7L	-82.95T	-7L	-10.9L	-14.59L
Total Equity	7L	-82.95T	-7L	-10.9L	-14.59L
Total Liabilities And Equity	8L	1L	76.89T	63.9T	82.82T
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.94Cr	2.94Cr	3.39Cr	3.52Cr	3.84Cr
ECS Total Common Shares Outstanding	2.94Cr	2.94Cr	3.39Cr	3.52Cr	3.84Cr
Book Value / Share	0.02	-0	-0.02	-0.03	-0.04
Tangible Book Value	7L	-82.95T	-7L	-10.9L	-14.59L
Tangible Book Value Per Share	0.02	-0	-0.02	-0.03	-0.04
Total Debt	0	41.14T	2L	3L	3L
Net Debt	-6L	12.23T	1L	3L	2L
Debt Equivalent Oper. Leases	2L	4L	11.58L	8L	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	2.32T	-	4.17T	-
Inventories - Finished Goods, Total	4T	-	17.24T	24.67T	-
Machinery, Total	30.43T	32.51T	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-23.94L	-8L	-8L	-5L	-6L
Depreciation & Amortization - CF	8.02T	6.73T	3.24T	2.12T	-
Depreciation & Amortization, Total	8.02T	6.73T	3.24T	2.12T	-
Asset Writedown & Restructuring Costs	7L	-	-	-	-
Stock-Based Compensation (CF)	-	-	37.7T	-	68.46T
Provision and Write-off of Bad Debts	-	52	61.29T	-	-
Other Operating Activities, Total	8L	-5.31T	55.33T	-43.53T	15.06T
Change In Accounts Receivable	-44.01T	36.16T	-5.08T	-26.67T	21.22T
Change In Inventories	37.46T	813	-25.76T	-11.59T	10.57T
Change In Accounts Payable	-79.53T	79.63T	3L	4L	4L
Change in Other Net Operating Assets	2.6T	5.17T	4.26T	3.52T	-
Cash from Operations	-9L	-7L	-3L	-2L	-76.44T
Capital Expenditure	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	11.58L	-	-	-	-
Cash from Investing	11.58L	-	-	-	-
Short Term Debt Issued, Total	-	27.24T	-	-	-
Long-Term Debt Issued, Total	-	20T	2L	65.66T	-
Total Debt Issued	-	47.24T	2L	65.66T	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-10T	-	-
Total Debt Repaid	-	-	-10T	-	-
Issuance of Common Stock	-	-	2L	67.63T	1L
Other Financing Activities, Total	-	-	-16T	-	-
Cash from Financing	-	47.24T	4L	1L	1L
Foreign Exchange Rate Adjustments	-4.88T	4.9T	-186	-	-1.06T
Net Change in Cash	3L	-6L	19.95T	-45.54T	68.98T
Supplemental Items
Levered Free Cash Flow	-2L	-3L	-23.7T	-13.77T	86.15T
Unlevered Free Cash Flow	-2L	-3L	-4.27T	17.44T	1L
Change In Net Working Capital	-8L	-1L	-4L	-3L	-4L
Net Debt Issued / Repaid	-	47.24T	2L	65.66T	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-47.38	-106.51	-527.61	-425.32	-509.64
Return on Total Capital	-49.96	-140.26	191.31	46.73	37.42
Return On Equity %	-125.51	-254.83	221.25	52.36	49.52
Return on Common Equity	-125.51	-254.83	221.25	52.36	49.52
Margin Analysis
Gross Profit Margin %	-292.67	97.07	69.86	75.71	58.63
SG&A Margin	344.55	584.47	1.13T	485.89	838.93
EBITDA Margin %	-674.15	-534.68	-1.23T	-421.25	-878.02
EBITA Margin %	-677.71	-539.55	-1.24T	-423.12	-881.14
EBIT Margin %	-677.71	-539.55	-1.24T	-423.12	-881.14
Income From Continuing Operations Margin %	-1.06T	-574.76	-1.31T	-402.95	-929.86
Net Income Margin %	-1.06T	-574.76	-1.31T	-402.95	-929.86
Net Avail. For Common Margin %	-1.06T	-574.76	-1.31T	-402.95	-929.86
Normalized Net Income Margin	-458.93	-359.22	-836.32	-251.84	-581.16
Levered Free Cash Flow Margin	-81.55	-243.51	-38.26	-12.16	126.9
Unlevered Free Cash Flow Margin	-81.55	-243.24	-6.9	15.4	173.26
Asset Turnover
Asset Turnover	0.11	0.32	0.68	1.61	0.93
Fixed Assets Turnover	14.22	16.05	16.08	-	-
Receivables Turnover (Average Receivables)	3.58	2.09	2.2	8.08	4.59
Inventory Turnover (Average Inventory)	1.98	1.28	1.91	1.19	-
Short Term Liquidity
Current Ratio	11.89	0.59	0.11	0.06	0.05
Quick Ratio	11.63	0.53	0.08	0.03	0.05
Operating Cash Flow to Current Liabilities	-13.9	-3.95	-0.47	-0.15	-0.05
Days Sales Outstanding (Average Receivables)	101.91	174.4	165.8	45.31	79.46
Days Outstanding Inventory (Average Inventory)	183.97	284.8	191.19	306.67	-
Average Days Payable Outstanding	25.38T	3.66T	435.38	873.86	-
Cash Conversion Cycle (Average Days)	-25.09T	-3.2T	-78.39	-521.87	-
Long Term Solvency
Total Debt/Equity	-	-49.59	-29.54	-24.62	-19.4
Total Debt / Total Capital	-	-98.37	-41.92	-32.66	-24.07
LT Debt/Equity	-	-21.78	-2.8	-	-
Long-Term Debt / Total Capital	-	-43.2	-3.98	-	-
Total Liabilities / Total Assets	8.28	179.09	948.12	1.81T	1.86T
EBIT / Interest Expense	-	-1.27T	-24.69	-9.59	-11.88
EBITDA / Interest Expense	-	-1.26T	-24.58	-9.55	-11.84
(EBITDA - Capex) / Interest Expense	-	-1.26T	-24.58	-9.55	-11.84
Total Debt / EBITDA	-	-0.06	-0.25	-0.56	-0.47
Net Debt / EBITDA	0.43	-0.02	-0.19	-0.56	-0.35
Total Debt / (EBITDA - Capex)	-	-0.06	-0.25	-0.56	-0.47
Net Debt / (EBITDA - Capex)	0.43	-0.02	-0.19	-0.56	-0.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-70.01	-38.58	-55.17	82.8	-40.04
Gross Profit, 1 Yr. Growth %	-226.41	-120.37	-67.74	98.12	-53.57
EBITDA, 1 Yr. Growth %	62.22	-51.29	3.43	-37.58	24.98
EBITA, 1 Yr. Growth %	61.59	-51.1	2.93	-37.56	24.87
EBIT, 1 Yr. Growth %	61.59	-51.1	2.93	-37.56	24.87
Earnings From Cont. Operations, 1 Yr. Growth %	102.03	-66.83	2.4	-43.9	38.37
Net Income, 1 Yr. Growth %	102.03	-66.83	2.4	-43.9	38.37
Normalized Net Income, 1 Yr. Growth %	45.85	-51.93	4.37	-44.95	38.37
Diluted EPS Before Extra, 1 Yr. Growth %	83.4	-66.83	-0.79	-51.37	35.96
Accounts Receivable, 1 Yr. Growth %	68.2	-32.42	-94.32	726.68	-81.8
Inventory, 1 Yr. Growth %	-99.55	-42.12	644.84	67.24	-
Net Property, Plant and Equip., 1 Yr. Growth %	-41.23	-52.99	-60.01	-	-
Total Assets, 1 Yr. Growth %	-76.32	-86.38	-26.69	-16.89	29.61
Tangible Book Value, 1 Yr. Growth %	-70.16	-111.75	686.12	67.22	33.81
Common Equity, 1 Yr. Growth %	-77.28	-111.75	686.12	67.22	33.81
Cash From Operations, 1 Yr. Growth %	-36.05	-24.27	-49.91	-46.78	-57.25
Levered Free Cash Flow, 1 Yr. Growth %	-82.17	83.39	-92.96	-41.89	-725.64
Unlevered Free Cash Flow, 1 Yr. Growth %	-82	83.19	-98.73	-508.1	574.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-13.75	-57.08	-47.53	-9.47	4.7
Gross Profit, 2 Yr. CAGR %	52.27	-49.26	-74.36	-20.05	-4.09
EBITDA, 2 Yr. CAGR %	34.85	-11.11	-29.02	-19.65	-11.67
EBITA, 2 Yr. CAGR %	35	-11.11	-29.06	-19.84	-11.7
EBIT, 2 Yr. CAGR %	35	-11.11	-29.06	-19.84	-11.7
Earnings From Cont. Operations, 2 Yr. CAGR %	69.22	-18.14	-41.72	-24.2	-11.89
Net Income, 2 Yr. CAGR %	69.22	-18.14	-41.72	-24.2	-11.89
Normalized Net Income, 2 Yr. CAGR %	40.57	-16.27	-29.17	-24.2	-12.72
Diluted EPS Before Extra, 2 Yr. CAGR %	25.56	-22	-42.63	-30.54	-18.69
Accounts Receivable, 2 Yr. CAGR %	29.97	6.62	-80.4	-31.47	22.67
Inventory, 2 Yr. CAGR %	-81.03	-94.89	107.62	252.94	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-36.09	-47.44	-56.64	-	-
Total Assets, 2 Yr. CAGR %	-35.31	-82.04	-68.4	-21.95	3.78
Tangible Book Value, 2 Yr. CAGR %	-9.95	-81.28	-3.9	262.56	49.58
Common Equity, 2 Yr. CAGR %	-30.87	-83.66	-3.9	262.56	49.58
Cash From Operations, 2 Yr. CAGR %	-3.59	-30.41	-38.41	-48.37	-52.31
Levered Free Cash Flow, 2 Yr. CAGR %	-48.08	-42.81	-64.06	-79.77	90.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-47.25	-42.57	-84.74	-77.22	424.66
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	32.63	-22.98	-56.45	-20.46	-21.09
Gross Profit, 3 Yr. CAGR %	99.84	-22.12	-56.37	-49.32	-33.3
EBITDA, 3 Yr. CAGR %	-	-3.96	-6.5	-32	-6.9
EBITA, 3 Yr. CAGR %	54.58	-3.77	-6.66	-32.02	-7.07
EBIT, 3 Yr. CAGR %	54.58	-3.77	-6.66	-32.02	-7.07
Earnings From Cont. Operations, 3 Yr. CAGR %	67.61	-1.7	-11.79	-42.45	-7.36
Net Income, 3 Yr. CAGR %	67.61	-1.7	-11.79	-42.45	-7.36
Normalized Net Income, 3 Yr. CAGR %	48.11	-1.7	-9.89	-34.88	-7.36
Diluted EPS Before Extra, 3 Yr. CAGR %	37.21	-19.43	-15.49	-45.71	-13.12
Accounts Receivable, 3 Yr. CAGR %	25.44	4.51	-59.88	-31.78	-55.95
Inventory, 3 Yr. CAGR %	-46.09	-72.48	-73.11	93.18	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-42.31	-52.02	-	-
Total Assets, 3 Yr. CAGR %	-34.38	-61.51	-71.3	-56.38	-7.57
Tangible Book Value, 3 Yr. CAGR %	-23.59	-54.33	-34.93	15.58	160.06
Common Equity, 3 Yr. CAGR %	-31.42	-61.71	-40.58	15.58	160.06
Cash From Operations, 3 Yr. CAGR %	32.25	-11.04	-37.63	-41.34	-51.52
Levered Free Cash Flow, 3 Yr. CAGR %	3.17	-20.93	-71.55	-57.82	-36.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.4	-20.12	-83.87	-54.36	-29.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	35.62	-8.47	-17.84	-38.15
Gross Profit, 5 Yr. CAGR %	-	34.82	-12.11	-21.3	-40.21
EBITDA, 5 Yr. CAGR %	-	-	-	-10.57	-8.61
EBITA, 5 Yr. CAGR %	-	43.47	13.2	-10.55	-8.71
EBIT, 5 Yr. CAGR %	-	43.47	13.2	-10.55	-8.71
Earnings From Cont. Operations, 5 Yr. CAGR %	-	39.99	9.85	-11.41	-11.83
Net Income, 5 Yr. CAGR %	-	39.99	9.85	-11.41	-11.83
Normalized Net Income, 5 Yr. CAGR %	-	39.99	10.27	-11.41	-11.03
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-14.79	-3.19	-24.08	-16.79
Accounts Receivable, 5 Yr. CAGR %	-	33.52	-40.31	-11.72	-37.26
Inventory, 5 Yr. CAGR %	-	-	-7.55	-23.65	-
Total Assets, 5 Yr. CAGR %	-	-34.93	-51.01	-48.93	-52
Tangible Book Value, 5 Yr. CAGR %	-	14.91	-16.25	4.6	-9.22
Common Equity, 5 Yr. CAGR %	-	-31.88	-21.51	-5.9	-14.04
Cash From Operations, 5 Yr. CAGR %	-	36.07	-2.58	-28.44	-43.98
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-32.33	-54.16	-39.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-50.24	-51.64	-35.07